Real-time enrollment status for this respiratory syncytial virus (rsv) clinical trial
Current Status
Recruiting
Checked: November 12, 2026 at 10:03 AM UTC
| NCT Number | NCT07839871 |
| Recruiting Status | Recruiting |
| Condition | Respiratory Syncytial Virus (RSV) |
| Phase | PHASE3 |
| Target Enrollment | 920 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | November 6, 2026 (6 days ago) |
As of November 12, 2026: Clinical trial NCT07839871 is currently recruiting participants. This phase3 study for respiratory syncytial virus (rsv) is actively seeking new participants at 5 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07839871 is actively recruiting participants as of November 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07839871 was last updated 6 days ago (November 6, 2026). HelloStudys verifies this status automatically.